Speaker illustration

Doctor Mitchel Tate

Monash University, Melbourne (Australia)

Cardiac-selective targeting of histone deacetylase 4 to limit experimental diabetic cardiomyopathy.

Event: ESC Congress 2018

Topic: Gene Therapy, Cell Therapy

Session: Cardiomyopathies

Thumbnail

Cardiac-selective bone morphogenetic protein 7 (BMP7) gene therapy to target cardiac fibrosis in a mouse model of diabetic cardiomyopathy.

Event: ESC CONGRESS 2017

Topic: Genetics and gene therapy

Session: Cardiovascular care - Biology II

Thumbnail

This platform is supported by

logo Novo Nordisk